Go to:
Logótipo
Você está em: Start > Publications > View > Regulatory pathways and uptake of L-DOPA by capillary cerebral endothelial cells, astrocytes, and neuronal cells
Map of Premises
Principal
Publication

Regulatory pathways and uptake of L-DOPA by capillary cerebral endothelial cells, astrocytes, and neuronal cells

Title
Regulatory pathways and uptake of L-DOPA by capillary cerebral endothelial cells, astrocytes, and neuronal cells
Type
Article in International Scientific Journal
Year
2001
Authors
Benedita Sampaio-Maia
(Author)
FMDUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Paula Serrão
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Soares-da-Silva P
(Author)
FMDUP
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Vol. 280 No. 2
Pages: C333-C342
ISSN: 0363-6143
Indexing
Publicação em ISI Web of Science ISI Web of Science
Pubmed / Medline
Scientific classification
FOS: Medical and Health sciences > Other medical sciences
CORDIS: Health sciences
Other information
Authenticus ID: P-000-WE2
Abstract (EN): We examined the nature and regulation of the inward L-3,4-dihydroxyphenylalanine (L-DOPA) transporter in rat capillary cerebral endothelial (RBE4) cells, type 1 astrocytes (DI TNC1), and Neuro-2a neuroblastoma cells. In all three cell types, the inward transfer of L-DOPA was largely promoted through the 2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid-sensitive and sodium-independent L-type amino acid transporter. Only in DI TNC1 cells was the effect of maneuvers that increase intracellular cAMP levels accompanied by increases in L-DOPA uptake. Also, only in DI TNC1 cells was the effect of the guanylyl cyclase inhibitor LY-83583 accompanied by a 65% increase in L-DOPA accumulation, whereas the nitric oxide donor sodium nitroprusside produced a 25% decrease in L-DOPA accumulation. In all three cell types, the Ca2+/calmodulin inhibitors calmidazolium and trifluoperazine inhibited L-DOPA uptake in a noncompetitive manner. Thapsigargin (1 and 3 microM) and A-23187 (1 and 3 microM) failed to alter L-DOPA accumulation in RBE4 and Neuro-2a cells but markedly increased L-DOPA uptake in DI TNC1 cells. We concluded that L-DOPA in RBE4, DI TNC1, and Neuro-2a cells is transported through the L-type amino acid transporter and appears to be under the control of Ca2+/calmodulin-mediated pathways. Astrocytes, however, are endowed with other processes that appear to regulate the accumulation of L-DOPA, responding positively to increases in intracellular Ca2+ and cAMP and to decreases in cGMP.
Language: English
Type (Professor's evaluation): Scientific
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

Regulation of apical transporter of L-DOPA in human intestinal Caco-2 cells (2002)
Article in International Scientific Journal
Sónia Fraga; Benedita Sampaio-Maia; Paula Serrão; Soares-da-Silva P

Of the same journal

Uptake and intracellular fate of l-DOPA in a human intestinal epithelial cell line: Caco-2 (1998)
Article in International Scientific Journal
vieira-coelho, ma; Soares-Da-Silva, P
Uptake and intracellular fate of L-DOPA in a human intestinal epithelial cell line: Caco-2 (1998)
Article in International Scientific Journal
vieira-coelho, ma; soares-da-silva, p
The short-chain fatty acid butyrate is a substrate of breast cancer resistance protein (2011)
Article in International Scientific Journal
Gonçalves P; Gregório, Maria João; Martel, F
Regulatory pathways and uptake ofl-DOPA by capillary cerebral endothelial cells, astrocytes, and neuronal cells (2001)
Article in International Scientific Journal
Benedita Sampaio-Maia; Serrão, MP; Soares-da-Silva, P
Recommend this page Top
Copyright 1996-2025 © Faculdade de Medicina Dentária da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-12 at 14:52:01 | Privacy Policy | Personal Data Protection Policy | Whistleblowing | Electronic Yellow Book